Phase 1 Study Of The Parp Inhibitor E7449 As A Single Agent In Patients With Advanced Solid Tumors Or R-Cell Lymphoma.Ruth Plummer,Divyanshu Dua,Nicola Cresti, Aneta Suder,Yvette Drew,Vasanthi Prathapan,Peter Stephens, Jared K. Thornton, Begona De Las Heras, Barbara Ink,Lucy Lee,Mark Matijevic,Shannon Mcgrath,Dobashis SarkerJOURNAL OF CLINICAL ONCOLOGY(2014)引用 4|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要